Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gradual deterioration of cognitive functions in Alzheimer's disease is paralleled by a hierarchical progression of amyloid-beta and tau brain pathology. Recent findings indicate that toxic oligomers of amyloid-beta may cause propagation of pathology in a prion-like manner, although the underlying mechanisms are incompletely understood. Here we show that small extracellular vesicles, exosomes, from Alzheimer patients' brains contain increased levels of amyloid-beta oligomers and can act as vehicles for the neuron-to-neuron transfer of such toxic species in recipient neurons in culture. Moreover, blocking the formation, secretion or uptake of exosomes was found to reduce both the spread of oligomers and the related toxicity. Taken together, our results imply that exosomes are centrally involved in Alzheimer's disease and that they could serve as targets for development of new diagnostic and therapeutic principles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, in damaged environments, like AD, exosomes are involved in the transportation of damaging proteins like Aβ and Tau [116].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [116]
The cited source says what the claim attributes to it.
In the citing paper
“A previous study has shown that sEVs isolated from the brains of AD patients contain elevated levels of Aβ oligomers [141].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“These EVs have been discovered as possible transporters for transferring toxic protein species from neuron to neuron, as has been shown in vitro.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“oAβ42 has been detected within neuronal exosomes.”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Data from cells treated with these exosomes also revealed that the exosomes facilitated delivery of oAβ42 and induced toxic effects [24].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200 · cited 1×
“These findings suggest that exosomes might be the main mediator of the pathogenic progression in AD as was recently suggested for dementia with Lewy bodies [41].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 2×
“It has been suggested that exosomal release may provide an alternative disposal mechanism to lysosomal degradation of oAβ [5] or other proteins that are resistant to degradation [55].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The nature of the propagating species has not been established, although several studies have indicated a particularly pathogenic role of soluble oAβ on synaptic and cellular functions and structure [13, 32, 50, 60].”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“1 3 Aß, tau and α-synuclein [12, 17, 46, 59] and can propagate tau pathology [4].”
BackgroundAlzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 2×
“Accordingly, exosomes from blood [22], CSF [17, 49] and cell cultures [46] have been shown to contain monomeric Aβ and tau, but so far, no study has addressed the presence of oAβ in exosomes from human AD brains.”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 1×
“Here dystrophic neurites with neurite beading and loss of neurite branching were identified, known early signs of neurodegeneration [51].”
Background
Research works printed but not linked: 1
- Tucker S, Möller C, Tegerstedt K, Lord A, Laudon H, Sjödahl J, Söderberg L, Spens E, Sahlin C, Waara ER et al (2015) The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. JAD 43:575–588. https://doi.org/10.3233/JAD-140741 · DOI · Paper page
Cited by
Items 301–400 of 530
Extracellular vesicles and their diagnostic potential in amyotrophic lateral sclerosis
Roy, J. W., Saucier, D., O’Connell, C. M., & Morin, P. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.012 · Cited by 16
Ji, W., Li, Y., Liu, R., Lü, Z., Liu, L., Shi, Z., Shen, J., & Zhang, X. (2021) · Materials Horizons · doi:10.1039/d0mh01542c · Cited by 14
Karamichali, E., Foka, P., Papadopoulou, G., Loukaki-Gkountara, D., Andresaki, K., Koskinas, J. S., & Georgopoulou, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810862 · Cited by 15
“For example, it was shown that in Alzheimer’s disease (AD), CNS-derived exosomes contain amyloidogenic proteins, such as hyperphosphorylated tau [76–78] and monomeric or oligomeric amyloid β-protein (Aβ) [79,80], while in Parkinson’s disease (PD), they can carry misfolded α-synuclein [81].”
BackgroundAlzheimer’s Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links
Zhang, M., Hu, S., & Sun, X. (2023) · Life · doi:10.3390/life13020373 · Cited by 20
Extracellular Vesicles in Premature Aging and Diseases in Adulthood Due to Developmental Exposures
Pinson, M. R., Chung, D. D., Adams, A. M., Scopice, C., Payne, E. A., Sivakumar, M., & Miranda, R. C. (2021) · Aging and Disease · doi:10.14336/ad.2021.0322 · Cited by 15
“inter-neuron transfer, propagating the AD pathology in a prion-like manner [206].”
BackgroundBartley, S. C., Proctor, M. T., Xia, H., Ho, E., Kang, D. S., Schuster, K. H., Bicca, M. A., Seckler, H. S., Viola, K. L., Patrie, S. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042208 · Cited by 14
“Current thinking favors the idea that pathological AβOs and pTau in Alzheimer’s disease are spread extracellularly by exosomes [96,97].”
BackgroundGhosh, S., & Ghosh, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878058 · Cited by 13
“Inhibition of the formation, secretion, or uptake of exosomes has been found to reduce both the spread of oligomers and the related toxicity (Sinha et al., 2018).”
BackgroundDeng, Z., Chen, H., Chen, J., Du, Z., Zhou, W., & Yuan, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167960 · Cited by 17
Arbaciauskaite, S., Silvestri, S., Luo, P., Krüger, C., Mossmann, Z. J., Allelein, S., Scholz, A., Löffler, D., Fiorenza, S., Menale, A., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05719-w · Cited by 16
“For example, EVs are involved in Aβ and Tau cell-to-cell spreading and neurotoxicity [19, 20].”
Sintakova, K., & Romanyuk, N. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1400413 · Cited by 15
Liu, Z., Cheng, L., Cao, W., Shen, C., Qiu, Y., Li, C., Xiong, Y., Yang, S., Chen, Z., Yin, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135826 · Cited by 14
Wang, B., Le, D., Liu, J., Zhang, X., Yang, F. N., Lai, G.-R., Zhang, C., Zhao, M.-L., Shen, Y.-P., Liao, P.-S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101782 · Cited by 16
Biofluid biomarkers for Alzheimer’s disease: past, present, and future
An, C., Cai, H., Ren, Z., Fu, X., Quan, S., & Jia, L. (2024) · Medical Review · doi:10.1515/mr-2023-0071 · Cited by 14
Arif, S., Qazi, T. J., Quan, Z., Ni, J., Li, Z., Qiu, Y., & Qing, H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102614 · Cited by 13
Wiersema, A. F., Rennenberg, A., Smith, G., Varderidou‐Minasian, S., & Pasterkamp, R. J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05522-7 · Cited by 15
Choi, Y., Kim, S.-M., Heo, Y., Lee, G., Kang, J. Y., & Yoon, D. S. (2020) · Nanotechnology · doi:10.1088/1361-6528/abba58 · Cited by 13
Dar, G. H., Badierah, R., Nathan, E., Bhat, M. A., Dar, A. H., & Redwan, E. M. M. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.967231 · Cited by 14
Extracellular chaperone networks and the export of J-domain proteins
Braun, J. E. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102840 · Cited by 17
Cazzaro, S., Fang, C. C., Khan, H., Witas, R., Kee, T. R., Woo, J. A., & Kang, D. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.933979 · Cited by 12
Batabyal, R., Bansal, A., Cechinel, L. R., Authelet, K. J., Goldberg, M., Nadler, E. P., Keene, C. D., Jayadev, S., Domoto‐Reilly, K., Li, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814024 · Cited by 15
“Although previous reports have identified EVs as potential carriers of important molecules involved in AD pathophysiology, including A β and tau [28–30], and several differentially expressed miRNAs have been identified in the blood, brain, and CSF of patients with AD, this work identifies that ad-sEVs…”
Specific Binding of Alzheimer’s Aβ Peptides to Extracellular Vesicles
Coughlan, C. M., Lindenberger, J. J., Jacot, J. G., Johnson, N. R., Anton, P. E., Bevers, S. G., Welty, R. S., Graner, M. W., & Potter, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073703 · Cited by 14
Eudesmane-type sesquiterpenoids: Structural diversity and biological activity
Wu, G.-X., Zhao, H., Peng, C. Y., Liu, F., & Xiong, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35270 · Cited by 12
Kanuri, S. H., & Sirrkay, P. J. (2024) · Brain Circulation · doi:10.4103/bc.bc_113_23 · Cited by 13
Gangliosides modulate the secretion of extracellular vesicles and their misfolded protein cargo
Monyror, J., Kadam, V., Morales, L. C., Ordóñez, D., Ibanga, J., Zaidi, A. K., McNamara, E., Pink, D., Stenlund, M. J., Reyes, K., et al. (2025) · Science Advances · doi:10.1126/sciadv.ady5212 · Cited by 12
Midazolam alleviates cellular senescence in SH‐SY5Y neuronal cells in Alzheimer's disease
Wang, P., Wang, P., Luan, H., Wu, Y., & Chen, Y. (2022) · Brain and Behavior · doi:10.1002/brb3.2822 · Cited by 13
Upadhyay, A., Sundaria, N., Dhiman, R., Prajapati, V. K., Prasad, A., & Mishra, A. (2021) · The Neuroscientist · doi:10.1177/1073858421989582 · Cited by 12
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 22
Alzheimer’s Disease and Its Possible Evolutionary Origin: Hypothesis
Whitfield, J. F., Rennie, K., & Chakravarthy, B. (2023) · Cells · doi:10.3390/cells12121618 · Cited by 12
Ali, T., Klein, A. N., McDonald, K., Johansson, L. E., Mukherjee, P. G., Hallbeck, M., Doh‐ura, K., Schätzl, H. M., & Gilch, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02858-y · Cited by 12
Self-citationChang, W., Xiao, D., Fang, X., & Wang, J. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.09.013 · Cited by 12
Manolopoulos, A., York, W., Pucha, K. A., Earley, C. J., & Kapogiannis, D. (2024) · Annals of Neurology · doi:10.1002/ana.26941 · Cited by 11
“14,15 Conversely, TfR, the primary cellular iron importer, was found to be decreased in NDEVs of RLS patients, suggesting diminished neuronal capacity for iron import.”
Amyloid-β oligomer-induced neurotoxicity by exosomal interactions between neuron and microglia
Tong, M. K., Thakur, A., Yang, T., Wong, S. K., Li, W. K., & Lee, Y. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150312 · Cited by 11
Counil, H., Silva, R. O., Rabanel, J., Zaouter, C., Haddad, M., Khedher, M. R. B., Brambilla, D., Fülöp, T., Patten, S. A., & Ramassamy, C. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70027 · Cited by 12
Glial and blood-brain barrier cell-derived exosomes: Implications in stroke
Mathias, K., Machado, R. S., Petronilho, T., Sulzbacher, V. A. R., de Rezende, V. L., Prophiro, J. S., & Petronilho, F. C. (2025) · Microvascular Research · doi:10.1016/j.mvr.2025.104812 · Cited by 10
Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases
Varshney, V., Gabble, B. C., Bishoyi, A. K., Varma, P., Qahtan, S. A., Kashyap, A., Panigrahi, R., Nathiya, D., & Chauhan, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05026-w · Cited by 14
“These proteins can distribute from one cell to another, exacerbating neurodegeneration [50].”
Advances in Intranasal Delivery of Exosomes for Central Nervous System Disorders
Arjmand, B., Mojavezi, A. R., Kamroo, A., Yazdi, R. K., Rezaei–Tavirani, M., & Vahedi, M.-S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05563-4 · Cited by 13
Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster
Elovsson, G., Bergkvist, L., & Brorsson, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910448 · Cited by 10
A comprehensive decoding of cognitive load
Zhu, X., Korivand, S., Hamill, K., Jalili, N., & Gong, J. (2022) · Smart Health · doi:10.1016/j.smhl.2022.100336 · Cited by 10
Upregulation of endocytic protein expression in the Alzheimer’s disease male human brain
Alsaqati, M., Thomas, R. S., & Kidd, E. J. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100084 · Cited by 12
Extracellular Vesicles in Neurological Disorders
Mazurskyy, A., & Howitt, J. A. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_16 · Cited by 13
Exosomes can spread toxic AD pathology
Fyfe, I. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0039-2 · Cited by 10
Exosomes: Biological Couriers with Transformative Messages
Yousef, M. H., & Abdelnaser, A. (2019) · Journal of Biomedicine · doi:10.7150/jbm.34611 · Cited by 10
Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons
Tohumeken, Ş., Deme, P., Yoo, S. W., Gupta, S., Rais, R., Slusher, B. S., & Haughey, N. J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.105987 · Cited by 9
Singh, P. J., Verma, B., Wells, A., Mendes, C. C., Dunn, D., Chen, Y.-N., Oh, J., Blincowe, L., Wainwright, S. M., Fischer, R., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00497-y · Cited by 11
“Furthermore, exosomes of unknown endosomal origin (Edgar et al, 2015) have a role in A β -peptide secretion, propagation and plaque formation (Sardar Sinha et al, 2018; Kaur et al, 2021), and exosome-containing compartments have recently been implicated in early A β oligomerisation events (Eckman…”
Extracellular vesicles as the drug delivery vehicle for gene-based therapy
Aquino, A. D., Rubinstein, A., Кудрявцев, И. В., Yakovlev, A. A., & Головкин, А. С. (2025) · Applied Physics Reviews · doi:10.1063/5.0255519 · Cited by 10
Surugiu, R., Burdusel, D., Ruscu, M.-A., Cercel, A., Hermann, D. M., Fernández‐Cadenas, I., & Popa‐Wagner, A. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_16 · Cited by 11
Ikeda, K., Sugiura, Y., Nakao, H., & Nakano, M. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107248 · Cited by 9
Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
Yoshida, S., & Hasegawa, T. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105307 · Cited by 9
Yong, Y., Cai, Y., Lin, J., Ma, L., Han, H., & Li, F. (2024) · Med-X · doi:10.1007/s44258-024-00021-7 · Cited by 13
Regulation of adult neurogenesis: the crucial role of astrocytic mitochondria
Liu, D., Guo, P., Wang, Y., & Li, W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1516119 · Cited by 9
Randhawa, S., Saini, T. C., Bathla, M., Bhardwaj, R., Dhiman, R., & Acharya, A. (2025) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.16.44 · Cited by 9
Liu, S., Feng, A., & Li, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05010-4 · Cited by 10
“NDEVs also transport pathological proteins like amyloid β (Aβ), α-synuclein (α-Syn), and tau, which can spread to peripheral neurons and contribute to the progression of neurodegenerative diseases [35–37].”
An, W., Jin, Z., & Li, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1708655 · Cited by 12
Salim, M. W., Zhang, W., Collins‐Praino, L. E., Wang, Y., & Care, A. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504608 · Cited by 8
Kamra, K., Lalam, S. K., Srivastava, S., Arumugam, M. K., Boopathy, L. K., Takkar, S., Xia, Z., & Subramanian, S. P. (2026) · Health Science Reports · doi:10.1002/hsr2.72638 · Cited by 10
Johansson, L. E., Reyes, J. F., Ali, T., Schätzl, H. M., Gilch, S., & Hallbeck, M. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05059-0 · Cited by 8
“Small extracellular vesicles (EVs), including exosomes, are important for cell-to-cell communication and play a significant role in the progression of multiple neurodegenerative diseases including Alzheimer’s disease (AD) [1].”
Self-citationBioengineering extracellular vesicles as novel nanocarriers towards brain disorders
Wu, J., Ma, L., Sun, D., Zhang, X., Cui, J., Du, Y., Guo, Y., Wang, X., Di, L., & Wang, R. (2022) · Nano Research · doi:10.1007/s12274-022-4913-2 · Cited by 8
del Río, J. A., & Ferrer, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.570692 · Cited by 10
Zhang, M., You, T., Guo, M., Zhao, Y., Shen, W., Wang, Y., Jiang, Y., Dong, Q., Yu, J., Cui, M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03838-5 · Cited by 9
Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging
Banihashemi, M. A., Krance, S. H., Ji, P. X., Koo, M., Ottoy, J., Swartz, R. H., Kertes, P. J., Hudson, C., Goubran, M., & Black, S. E. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70884 · Cited by 11
Generating exosome subtypes: diverse membrane origins and mergers
Goberdhan, D. C. I., Harris, A. L., & WILSON, C. G. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.03.009 · Cited by 10
Extracellular vesicles: the key to unlocking mechanisms of age-related vascular disease?
Whitehead, M., Antonazzi, M., & Shanahan, C. M. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.49 · Cited by 7
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Fang, X., Zhou, D., Wang, X., Ma, Y., Zhong, G., Jing, S., Huang, S., & Wang, Q. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03957-4 · Cited by 8
Wąchalska, M., Rychłowski, M., Grabowska, K., Kowal, K., Narajczyk, M., Bieńkowska-Szewczyk, K., & Lipińska, A. D. (2020) · Membranes · doi:10.3390/membranes10120373 · Cited by 8
Multiple roles of neuronal extracellular vesicles in neurological disorders
Jiao, Z., He, Z., Liu, N., Lai, Y., & Zhong, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.979856 · Cited by 7
Siniscalco, D., Francius, G., Tarek, M., Bali, S. K., Laprévôte, O., Malaplate, C., Oster, T., Gregory, L., & Quilès, F. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c22196 · Cited by 10
Berntsson, E., Paul, S., Vosough, F., Sholts, S. B., Jarvet, J., Roos, P. M., Barth, A., Gräslund, A., & Wärmländer, S. K. T. S. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5493 · Cited by 14
Muraoka, S., DeLeo, A. M., Sethi, M. K., Takamatsu-Yukawa, K., Yang, Z., Ko, J., Hogan, J., Ruan, Z., You, Y., Wang, Y., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/733477 · Cited by 7
“[12,13].”
Miao, X., Yue, W., Wang, J., Chen, J., Qiu, L., Paerhati, H., Zhou, Q., Li, P., Wu, A., & Zhang, M. (2025) · Current Neuropharmacology · doi:10.2174/011570159x417328250908080404 · Cited by 6
“AD development is closely associated with the spread of pathogenic Aβ and tau proteins, an event increasingly recognized to engage exosomes [65, 66].”
Ray, S., Kumar, M., Chemparathy, D. T., Dash, P. K., & Sil, S. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70191 · Cited by 7
Mulet, M., Milán, J. A. S., Lorca, C., Fernández‐Rhodes, M., Planell, A. A., Castillo, M. C. B., Saiz-Aúz, L., Mateos‐Moreno, M., Hase, Y., Mira, A., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101464 · Cited by 8
“Several authors, including us, have intensively contributed to improving the challenges that hinder the study of CNS-EVs by systems biology (31, 43) and to deciphering the potential neuropathological implications and biological marker abilities of brain EVs (bEVs) in dementias (44–46).”
Singh, R., Mishra, A., Kumar, V., Gupta, A., Zehra, S., Rani, N., Dhingra, R., Modi, G. P., Inampudi, K. K., Nikolajeff, F. K., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120761 · Cited by 8
Redefining the Limits of Nanodevices-Based Drug Delivery Systems: Extracellular Vesicles
Díaz, M. L., Simón, V., Benedini, L. A., & Messina, P. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121617 · Cited by 6
Holghoomi, R., Rahdar, A., Kadkhoda, J., Mohammadzadeh, V., Shirzad, M., Salehi, B., Ebrahimi, M.-S., & Pandey, S. (2026) · Nano LIFE · doi:10.1142/s179398442630013x · Cited by 6
Missorting of plasma miRNAs in aging and Alzheimer's disease
Čarná, M., Novotný, J., Dragišić, N., Slavík, H., Sheardová, K., Geda, Y. E., Vyhnálek, M., Laczó, J., Hort, J., Mao, Z., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15801 · Cited by 7
“…needs to be experimentally confirmed, measurements of these miRNAs offer a potential novel approach to sample the plasma EV content in AD without the need of purifying EVs and then measuring AD- specific protein changes (Wang et al., 2017; Sardar Sinha et al., 2018; Winston et al., 2019).”
BackgroundVigier, M., Uriot, M., Djelti, F., Claudepierre, T., Hajj, A. E., Yen, F. T., Oster, T., & Malaplate, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136816 · Cited by 6
“…µ M for 24 h or in the presence of DHA (Gibco) at 0.5 µ M for 48 h. Cells were either recovered for Western blot analysis in RIPA lysis buffer (Sigma Aldrich) supplemented with 40 µ g/mL cOmplete Protease Inhibitor Roche (Sigma Aldrich) or for immunostaining after fixation in 4% paraformaldehyde.”
MethodInfluentialWertman, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144202 · Cited by 6
LaRocca, T. J., & Lark, D. S. (2025) · Function · doi:10.1093/function/zqaf005 · Cited by 7
The Vicious Consequences of Chronic Kidney Disease on Cognitive Impairment and Alzheimer’s Disease
Roy, A., Roy, R., Bhattacharya, P., & Borah, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00050 · Cited by 7
Molecular engines driving biogenesis, trafficking and release of exosomes: SNARE proteins
Ogungbemi, D., Shorter, S. A., Asadollahi, R., Boussios, S., & Ovsepian, S. V. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100089 · Cited by 7
iTRAQ-Based Proteomic Analysis of APP Transgenic Mouse Urine Exosomes
Zhou, X., Sheikh, A. M., Matsumoto, K., Mitaki, S., Shibly, A. Z., Zhang, Y., Garu, A., Yano, S., & Nagai, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010672 · Cited by 8
“Indeed, recent reports showed the importance of exosome-mediated transport of Aβ in the pathology of AD [20,21].”
BackgroundKong, W., & Zang, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.959472 · Cited by 10
Kim, S. S., Jeon, J. K., Ganbat, D., Kim, T.-W., Shin, K., Hong, S., & Hong, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814064 · Cited by 7
Khedher, M. R. B., Haddad, M., Fülöp, T., Laurin, D., & Ramassamy, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230823 · Cited by 9
Extracellular vesicles in Alzheimer's disease
Pinho, V. H. B., Daher, J. P. L., Kanaan, S., & Medeiros, T. (2024) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0044-1779296 · Cited by 7
“…in vitro , a possible action of EVs in the pathogenesis of the disease, through the transmission of Aß in its neurotoxic form through the CNS. 43 47 One study in particular proved that this increase was present up to 10 years prior to AD diagnosis, as well as that these levels increased as…”
InfluentialStructure Dependent Differential Modulation of Aβ Fibrillization by Selenadiazole-Based Inhibitors
Kalsoom, U., Alazmi, M., Farrukh, H. S. U. B., Chung, K. H. K., Alshammari, N., Käkinen, A., Chotana, G. A., Javed, I., Davis, T. P., & Saleem, R. S. Z. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00478 · Cited by 7
Sugar distributions on gangliosides guide the formation and stability of amyloid-β oligomers
Saha, J., Ford, B. J., Wang, X., Boyd, S., Morgan, S. E., & Rangachari, V. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107073 · Cited by 6
Unlocking the potential of extracellular vesicles: one stimulus away from clinical implementation
Silva, R. M., Azevedo, A. M., Bonifácio, V. D. B., Fernandez-Becerra, C., & Pinto, S. N. (2025) · Biomaterials Science · doi:10.1039/d5bm01091h · Cited by 10
Vesicles: New Advances in the Treatment of Neurodegenerative Diseases
Nuzzo, D., Girgenti, A., Palumbo, L., Naselli, F., Bavetta, M., Marfia, G., & Picone, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312672 · Cited by 5
Soudy, R., Kimura, R., Fu, W., Patel, A., & Jhamandas, J. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267164 · Cited by 5
“In AD brains, EV markers, such as Alix, have been localized around amyloid plaques [8, 9].”
Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23
Long, Y., Cheng, Y., Yang, J., Yang, T., & Lai, Y. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136771 · Cited by 6
Study on plasma exosome biomarkers of pregnant women with intrahepatic cholestasis of pregnancy
Feng, F., Jiang, M., Liu, W., Xu, D., Huang, X.-M., & Shao, Y. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2029940 · Cited by 5
Recent trends of extracellular vesicles for therapeutic intervention of brain-related diseases
Handa, M., Reddy, G. A., Panicker, N., Singh, S., & Ruwali, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00007-1 · Cited by 5
The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases
Hagey, D. W., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00014-x · Cited by 6
Işık, M., Sari, H. K., Çağlayan, M. G., Yılmaz, R., & Derkuş, B. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70090 · Cited by 4
“For instance, exosomes derived from neuronal cell lines demonstrate that the introduction of AD-related mutations can elevate the levels of sAPP protein β, sAPPα, and soluble Aβ1-42 (Eitan et al. 2016; Sardar Sinha et al. 2018; Xiao et al. 2017).”
Exosome-Based Therapies in Dermatology
Aryal, S. (2025) · Aesthetic Plastic Surgery · doi:10.1007/s00266-025-05073-7 · Cited by 4
“Exosomes conduct wide array of functions including cell-to-cell communication [20], immune modulation [21], waste management [22], and, in pathological conditions like cancer, biomarker for cancer detection and progression [23].”
Extracellular vesicles in tumor microenvironment modulation and clinical diagnosis
Liu, H., Niu, D., Yu, T., Wang, Y.-H., Ran, K.-L., Liu, Y.-H., Yin, D.-C., & Zhang, C. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156339 · Cited by 5
Deshetty, U. M., Singh, S., Martínez-Cuevas, F. L., Jain, S., Buch, S. J., & Periyasamy, P. (2026) · Immuno · doi:10.3390/immuno6010012 · Cited by 5
Saleem, T., Möbius, W., Schmitz, M., Correia, A. D. S., Thomas, C., Canaslan, S., Hermann, P., Goebel, S., Zafar, S., Root, E., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02998-4 · Cited by 4
Extracellular Vesicles in Alzheimer’s Disease: Mechanisms, Biomarkers, and Therapeutic Engineering
Wang, L., Mao, L., & Zong, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093974 · Cited by 4
“EVs released from AD brain tissue are enriched in toxic oligomeric A β (oA β ), predominantly within the vesicle lumen, and these EVs are efficiently internalized by neurons, leading to propagation of neurotoxicity [77].”
Metadata
- Authors
- Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Uppsala University (SE)
- Corresponding author
- Hallbeck, Martin
- Venue
- Acta Neuropathologica
- Published
- 2018-06-13
- Volume
- 136
- Issue
- 1
- Pages
- 41-56
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6015111
- OpenAlex
- W2807776100
- Cited by
- 527
- References
- 60
- Citations by year
- 2026: 48 · 2025: 70 · 2024: 71 · 2023: 64 · 2022: 60 · 2021: 74 · 2020: 82 · 2019: 50 · 2018: 6
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Funders
- Vetenskapsrådet (523-2013-2735)
- Alzheimerfonden
- Hjärnfonden
- Hans-Gabriel och Alice Trolle Wachtmeister Stiftelse för Medicinsk forskning
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Knut och Alice Wallenbergs Stiftelse
- Demensförbundet
- Linköpings Universitet
- Region Östergötland
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, exosomes, amyloid-beta oligomers, prion-like propagation, extracellular vesicles, tau pathology, exosome secretion, exosome uptake, neurotoxicity
- MeSH terms
- Tsg101 Protein, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cell Line, Transformed, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, L-Lactate Dehydrogenase, Male, Membrane Proteins, Middle Aged, Neuroblastoma, Organic Chemicals, Peptide Fragments, Transcription Factors, Amyloid beta-Peptides, Culture Media, Conditioned, Coculture Techniques, Protein Transport, Pluripotent Stem Cells, Microscopy, Electron, Transmission, Exosomes, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.